Archive for 2004

China: how to seize "commanding point" of biotechnology

China: how to seize “commanding point” of biotechnology “China’s capital investment in the scientific research of life science is far from enough, and the government should create fine environment for the development of biotechnology industry, and mobilize all forces in the society to develop biotechnology and industry…”


Click here for reuse options!
Copyright 2004 Biotechblog

China: how to seize “commanding point” of biotechnology

China: how to seize “commanding point” of biotechnology “China’s capital investment in the scientific research of life science is far from enough, and the government should create fine environment for the development of biotechnology industry, and mobilize all forces in the society to develop biotechnology and industry…”


Click here for reuse options!
Copyright 2004 Biotechblog

Stem-Cell Cash on a Winding Road

Stem-Cell Cash on a Winding Road They may not be investing in the companies themselves, but venture capitalists haven’t completely abandoned stem-cell work. Instead, they’re contributing through efforts like the California Stem Cell Initiative…


Click here for reuse options!
Copyright 2004 Biotechblog

ImClone Hammered as Sales Lag Estimates

ImClone Hammered as Sales Lag Estimates Scandal-plagued ImClone Systems may have fallen off the road to recovery. While the company’s second-quarter earnings beat Wall Street estimates, the stock plunged yesterday on disappointing sales of the company’s key cancer drug.


Click here for reuse options!
Copyright 2004 Biotechblog

Wanted: Drugs to Fight Bioterror

Wanted: Drugs to Fight Bioterror “Amid new warnings about a possible summer of terror, the U.S. government is preparing to spend billons to coax pharmaceutical companies to develop drugs to fend off a biological or chemical attack. But experts say the infusion of cash may be little more than a good start.”


Click here for reuse options!
Copyright 2004 Biotechblog

Eco-Terror Cited as Top Threat

Eco-Terror Cited as Top Threat Law enforcement officials warn that biotechnology firms, particularly those that conduct research on animals, must take greater precautions against attacks by extremist groups.


Click here for reuse options!
Copyright 2004 Biotechblog

The Drug Research War

The Drug Research War “Mention the term ‘outsourcing,’ and drug development probably doesn’t leap to mind. But this market, which is the heart of pharmaceutical and biotech companies, is growing at a yearly clip of 15% to 20%. Right now the lion’s share of the work has gone to U.S. companies that focus on drug […]


Click here for reuse options!
Copyright 2004 Biotechblog

Biotechs struggle as IPOs find cool reception

Biotechs struggle as IPOs find cool reception “Five initial public offerings had trading debuts Thursday, bringing mixed results and a message that biotech certainly isn’t what the doctor ordered for the IPO market. “


Click here for reuse options!
Copyright 2004 Biotechblog

%d bloggers like this: